IRWD Earnings & Financial Statements
Ironwood Pharmaceuticals, Inc.
$3.83
+$0.23(+6.25%)
43
Overall
60
Value
27
Tech
44
Quality
Market Cap
$594.86M
Volume
540.40K
52W Range
$1.41 - $5.78
Target Price
$5.88
IRWD earnings and financial statements: Ironwood Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
IRWD Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $296.15M | $351.41M | $442.74M | $410.60M | $413.75M |
| Cost of revenue | - | - | - | - | $44.0K |
| Operating income | $98.50M | $93.12M | -$945.43M | $250.34M | $232.26M |
| EBITDA | $106.34M | $101.80M | -$944.43M | $263.29M | $257.18M |
| Net income | $24.02M | $880.0K | -$1.00B | $175.06M | $528.45M |
| EPS (diluted) | $0.15 | $0.01 | $-6.45 | $0.96 | $3.21 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $396.90M | $350.91M | $471.07M | $1.10B | $1.13B |
| Total liabilities | $622.35M | $618.71M | $817.37M | $448.14M | $521.02M |
| Shareholders’ equity | -$261.83M | -$301.33M | -$346.30M | $652.38M | $605.91M |
| Cash and equivalents | $215.46M | $88.56M | $92.15M | $656.20M | $620.13M |
| Long-term debt | $394.87M | $596.29M | $512.85M | $412.85M | $355.82M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $127.04M | $103.55M | $183.43M | $273.76M | $261.89M |
| Capital expenditure | -$34.0K | -$142.0K | -$273.0K | -$136.0K | -$265.0K |
| Free cash flow | $127.01M | $103.41M | $183.15M | $273.63M | $261.63M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IRWD | $3.83 | +6.3% | 540.40K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ironwood Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW